# Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol

> **NCT03484611** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 179 (estimated)

## Conditions studied

- Invitro Fertilizaion

## Interventions

- **DRUG:** GnRH antagonist
- **DRUG:** Gonadotropins
- **DRUG:** Human chorionic gonadotropin
- **PROCEDURE:** Embryo transfer
- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT03484611
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 179 (ESTIMATED)
- **Last updated:** 2018-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03484611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03484611, "Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03484611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*